Cranbrook Wealth Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.58K | Hold |
222
| – | – | ﹤0.01% | 349 |
|
|
2025
Q4 | $2.54K | Hold |
222
| – | – | ﹤0.01% | 365 |
|
|
2025
Q3 | $2.82K | Hold |
222
| – | – | ﹤0.01% | 364 |
|
|
2025
Q2 | $3.53K | Hold |
222
| – | – | ﹤0.01% | 349 |
|
|
2025
Q1 | $3.32K | Hold |
222
| – | – | ﹤0.01% | 346 |
|
|
2024
Q4 | $4.21K | Hold |
222
| – | – | ﹤0.01% | 322 |
|
|
2024
Q3 | $6.01K | Hold |
222
| – | – | ﹤0.01% | 291 |
|
|
2024
Q2 | $5.53K | Hold |
222
| – | – | ﹤0.01% | 269 |
|
|
2024
Q1 | $7.37K | Hold |
222
| – | – | ﹤0.01% | 244 |
|
|
2023
Q4 | $7.9K | Hold |
222
| – | – | ﹤0.01% | 245 |
|
|
2023
Q3 | $7.58K | Hold |
222
| – | – | ﹤0.01% | 237 |
|
|
2023
Q2 | $8.88K | Hold |
222
| – | – | ﹤0.01% | 232 |
|
|
2023
Q1 | $8.72K | Hold |
222
| – | – | ﹤0.01% | 231 |
|
|
2022
Q4 | $7.07K | Hold |
222
| – | – | ﹤0.01% | 236 |
|
|
2022
Q3 | $6K | Hold |
222
| – | – | ﹤0.01% | 264 |
|
|
2022
Q2 | $8K | Hold |
222
| – | – | ﹤0.01% | 253 |
|
|
2022
Q1 | $11K | Hold |
222
| – | – | ﹤0.01% | 270 |
|
|
2021
Q4 | $12K | Hold |
222
| – | – | ﹤0.01% | 273 |
|
|
2021
Q3 | $13K | Hold |
222
| – | – | ﹤0.01% | 276 |
|
|
2021
Q2 | $14K | Hold |
222
| – | – | ﹤0.01% | 261 |
|
|
2021
Q1 | $14K | Hold |
222
| – | – | ﹤0.01% | 267 |
|
|
2020
Q4 | $12K | Hold |
222
| – | – | ﹤0.01% | 229 |
|
|
2020
Q3 | $10K | Hold |
222
| – | – | ﹤0.01% | 214 |
|
|
2020
Q2 | $10K | Hold |
222
| – | – | ﹤0.01% | 212 |
|
|
2020
Q1 | $9K | Hold |
222
| – | – | ﹤0.01% | 204 |
|
|
2019
Q4 | $13K | Hold |
222
| – | – | ﹤0.01% | 200 |
|
|
2019
Q3 | $12K | Hold |
222
| – | – | ﹤0.01% | 195 |
|
|
2019
Q2 | $13K | Hold |
222
| – | – | ﹤0.01% | 186 |
|
|
2019
Q1 | $11K | Hold |
222
| – | – | ﹤0.01% | 192 |
|
|
2018
Q4 | $8K | Hold |
222
| – | – | ﹤0.01% | 191 |
|
|
2018
Q3 | $8K | Hold |
222
| – | – | ﹤0.01% | 190 |
|
|
2018
Q2 | $10K | Hold |
222
| – | – | ﹤0.01% | 180 |
|
|
2018
Q1 | $11K | Hold |
222
| – | – | ﹤0.01% | 178 |
|
|
2017
Q4 | $15K | Hold |
222
| – | – | 0.01% | 162 |
|
|
2017
Q3 | $13K | Hold |
222
| – | – | 0.01% | 168 |
|
|
2017
Q2 | $14K | Buy |
+222
| New | +$14K | 0.01% | 175 |
|
|
2016
Q2 | – | Sell |
-111
| Closed | -$7K | – | 216 |
|
|
2016
Q1 | $7K | Hold |
111
| – | – | ﹤0.01% | 170 |
|
|
2015
Q4 | $7K | Hold |
111
| – | – | ﹤0.01% | 168 |
|
|
2015
Q3 | $6K | Hold |
111
| – | – | ﹤0.01% | 177 |
|
|
2015
Q2 | $6K | Hold |
111
| – | – | ﹤0.01% | 180 |
|
|
2015
Q1 | $6K | Hold |
111
| – | – | ﹤0.01% | 179 |
|
|
2014
Q4 | $6K | Hold |
111
| – | – | ﹤0.01% | 183 |
|
|
2014
Q3 | $5K | Hold |
111
| – | – | ﹤0.01% | 139 |
|
|
2014
Q2 | $5K | Hold |
111
| – | – | ﹤0.01% | 138 |
|
|
2014
Q1 | $5K | Hold |
111
| – | – | ﹤0.01% | 137 |
|
|
2013
Q4 | $5K | Buy |
+111
| New | +$5.2K | ﹤0.01% | 187 |
|
Other funds holding XRAY
VPM
SCA
VCM
CB
AI
Cranbrook Wealth Management's XRAY Position: Q1 2026 in Review
Cranbrook Wealth Management held its Dentsply Sirona (XRAY) position steady in Q1 2026 at 222 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #349.
Cranbrook Wealth Management first reported a position in XRAY in Q4 2013 and has held it in 46 quarters since. The position peaked at $15K in Q4 2017. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.
- Cranbrook Wealth Management held 222 shares of Dentsply Sirona worth $2.58K as of Q1 2026.
- Cranbrook Wealth Management left its Dentsply Sirona share count unchanged in Q1 2026.
- Dentsply Sirona made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q1 2026, its #349 holding.
- Cranbrook Wealth Management first reported a position in Dentsply Sirona in Q4 2013 and has held it in 46 quarters since.
- Cranbrook Wealth Management's Dentsply Sirona position peaked at $15K in Q4 2017.
- 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.
Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.